Merck

Merck daiichi withdraw us application guided missile cancer drug - Merck & Daiichi Sankyo's withdrawal of the US application for their "guided missile" cancer drug raises crucial questions about the future of targeted therapies. This innovative approach,...

Merck held talks buy biotech Moonlake over 3 billion ft reports, sparking considerable interest in the pharmaceutical industry. This potential acquisition promises a fascinating look into Merck's strategic direction and the future of biotech innovation. The reported...